← Leaderboards
Kenneth S Knox
Indiana Univ-Purdue Univ At Indianapolis
$4,264,948
Attributed
$7,191,317
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $673.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,191,317 · 7
By mechanism
U01$3,161,796 · 1
R01$1,692,086 · 1
R42$1,337,106 · 1
K08$646,145 · 1
R41$299,905 · 1
M01$54,279 · 2
Top collaborators
- Homer L Twigg5 shared
- George M Weinstock5 shared
- Timothy A Marlowe3 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Janice S Blum$14,880,456
- Robert S. Tepper$17,766,613
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCellsPhenotypeT-LymphocyteCytokineMediatingBloodImmunologicsImmuneReconstitutionRestorationMacrophageResponseX-Ray Computed TomographyLymphocyteAutomobile DrivingCohortInflammatoryLeadFollow-UpCytomegalovirusLung DiseasesAntigensViral Load Result
Grant awards (20)
Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis$663,310
R42 · FY2025 · HL
Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis$673,796
R42 · FY2024 · HL
Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis$299,905
R41 · FY2022 · HL
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$631,713
U01 · FY2017 · HL
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$632,227
U01 · FY2016 · HL
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$634,026
U01 · FY2015 · HL
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$622,323
U01 · FY2014 · HL
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection$641,507
U01 · FY2013 · HL
Pulmonary CD4+ T-Cell Repopulation in Immune Reconstituion Syndrome$291,324
R01 · FY2009 · HL · contact PI
Pulmonary CD4+ T-Cell Repopulation in Immune Reconstituion Syndrome$302,399
R01 · FY2008 · HL · contact PI
PULMONARY CD4+ T-CELL RE-POPULATION IN IMMUNE RECONSTITUTION SYNDROME$10,449
M01 · FY2008 · RR · contact PI
Pulmonary CD4+ T-Cell Repopulation in Immune Reconstituion Syndrome$352,649
R01 · FY2007 · HL · contact PI
PULMONARY CD4+ T-CELL RE-POPULATION IN IMMUNE RECONSTITUTION SYNDROME$43,830
M01 · FY2007 · RR · contact PI
Pulmonary CD4+ T-Cell Repopulation in Immune Reconstitu*$363,182
R01 · FY2006 · HL · contact PI
Pulmonary CD4+ T-Cell Repopulation in Immune Reconstitu*$382,532
R01 · FY2005 · HL
MACROPHAGE ANTIGEN PROCESSING OF HIV SUBTYPES$119,733
K08 · FY2005 · HL
MACROPHAGE ANTIGEN PROCESSING OF HIV SUBTYPES$131,603
K08 · FY2004 · HL
MACROPHAGE ANTIGEN PROCESSING OF HIV SUBTYPES$131,603
K08 · FY2003 · HL
MACROPHAGE ANTIGEN PROCESSING OF HIV SUBTYPES$131,603
K08 · FY2002 · HL
MACROPHAGE ANTIGEN PROCESSING OF HIV SUBTYPES$131,603
K08 · FY2001 · HL